-
公开(公告)号：US20220199217A1
公开(公告)日：2022-06-23
申请号：US17535474
申请日：2021-11-24
Inventor： Sung Min PARK , Seung Hyun LEE
Abstract: A method of determining a continuous drug dose using reinforcement learning and a pharmacokinetic-pharmacodynamic model according to an embodiment of the present invention includes, measuring or estimating a patient's pharmacokinetic-pharmacodynamic model; training a reinforcement learning algorithm using drug infusion data and patient state data based on the pharmacokinetic-pharmacodynamic model; and automatically determining a continuous drug dose by the trained reinforcement learning algorithm.
-
Patent Agency Ranking
2.发明公开公开(公告)号：US20230148966A1
公开(公告)日：2023-05-18
申请号：US18093856
申请日：2023-01-06
Inventor： Jonghan KIM , Sung Min PARK , Jun Ho KIM , Young Jun HONG , Jongpal KIM
IPC: A61B5/00 , A61B5/11 , A61B5/0538 , A61B5/08 , A61B5/283
CPC classification number: A61B5/6847 , A61B5/1116 , A61B5/1118 , A61B5/1102 , A61B5/0538 , A61B5/0006 , A61B5/0809 , A61B5/283 , A61B2560/0219 , A61B2562/0247
Abstract: An implantable monitoring device includes first sensors to measure state information of one or both of a posture and an activity of a user and second sensors to measure bioinformation of two or more of an electrocardiogram (ECG) of a heart of the user, a pulmonary impedance of a lung of the user, a movement of the heart, a movement of a thorax including the lung, and a respiratory quotient (RQ) of the lung, two electrodes to detect bioinformation to measure one or both of the ECG and the pulmonary impedance, an analog circuit to process the detected bioinformation to measure the one or both of the ECG and the pulmonary impedance, and a processor to monitor an abnormal state of the heart and the lung of the user based on the state information and the bioinformation.
-
公开(公告)号：US20230381412A1
公开(公告)日：2023-11-30
申请号：US18027640
申请日：2020-10-26
Inventor： Sung Min PARK , Gang Wook KIM
CPC classification number: A61M5/1723 , G16H20/17 , G16H10/60 , G16H50/20 , A61M5/14244 , A61M5/16877 , G16H40/67
Abstract: A blood glucose control system according to an embodiment of the present invention includes a continuous blood glucose meter configured to continuously measuring blood glucose of a patient, a bio-signal sensor configured to acquire a bio-signal of the patient, a lifelog data collector configured to collect lifelog data of the patient, an insulin injection controller configured to determine an insulin injection amount and an injection rate based on one or more of blood glucose measurement information and blood glucose metabolism characteristic information received from the continuous blood glucose meter, the bio-signal acquired by the bio-signal sensor or a stress level of the patient indexed by the bio-signal, and the lifelog data collected by the lifelog data collector, and an insulin pump configured to inject insulin into a body of the patient according to the insulin injection amount and the injection rate determined by the insulin injection controller.
-
公开(公告)号：US20250001182A1
公开(公告)日：2025-01-02
申请号：US18510528
申请日：2023-11-15
Inventor： Won Ok KANG , Sung Min PARK
Abstract: The present disclosure relates to a sequential local electrical stimulation method. The sequential local electrical stimulation method according to the present disclosure includes determining a number and arrangement of electrodes included in an electrode array according to a structure of a target area, determining stimulation parameters including stimulation intensity, a stimulation sequence, and a stimulation pulse based on the structure of the target area, and sequentially applying stimulation in one direction from an outermost part of the electrode array by using the stimulation parameters.
-
公开(公告)号：US20220072318A1
公开(公告)日：2022-03-10
申请号：US17190594
申请日：2021-03-03
Inventor： Jaechun LEE , Sang Joon KIM , Won Ok KANG , Jonghan KIM , Jun Seung MUN , Sung Min PARK , Chisung BAE
Abstract: Implantable apparatuses are provided, where the implantable apparatus includes a first electrode, a second electrode, an electrode signal transceiver connected to the first electrode and the second electrode, an antenna, a wireless power receiver connected to the antenna, and a conductor case configured to protect the electrode signal transceiver and the wireless power receiver. The antenna be spaced apart from the conductor case and encloses the conductor case, and a plane in which the antenna is disposed is at a same level or at a higher level than a top surface of the conductor case.
-
公开(公告)号：US20210059606A1
公开(公告)日：2021-03-04
申请号：US16721972
申请日：2019-12-20
Inventor： Jonghan KIM , Sung Min PARK , Jun Ho KIM , Young Jun HONG , Jongpal KIM
Abstract: An implantable monitoring device includes first sensors to measure state information of one or both of a posture and an activity of a user and second sensors to measure bioinformation of two or more of an electrocardiogram (ECG) of a heart of the user, a pulmonary impedance of a lung of the user, a movement of the heart, a movement of a thorax including the lung, and a respiratory quotient (RQ) of the lung, two electrodes to detect bioinformation to measure one or both of the ECG and the pulmonary impedance, an analog circuit to process the detected bioinformation to measure the one or both of the ECG and the pulmonary impedance, and a processor to monitor an abnormal state of the heart and the lung of the user based on the state information and the bioinformation.
-
-
-
-
-
Search Results
6
records
(took 0.046 seconds)
